Lyophilization involves freeze drying of products. In pharmaceutical industries this process is widely used to increase the self-life of antibiotics, vaccines, and protein-based drugs. Biopharmaceutical companies are using lyophilization services to keep APIs and drugs sterile. Increasing good manufacturing practices are increasing demand of lyophilization services.
PCI Pharma Solutions and Curia Global Inc – Notable Market Players in Lyophilization Services for Biopharmaceuticals Market
The lyophilization services for biopharmaceuticals market comprises top players such as ATTWILL Medical Solutions; Axcellerate Pharma LLC; Labyrinth Biopharma LLC; Berkshire Sterile Manufacturing; PCI Pharma Services; Curia Global Inc; Emergent BioSolutions Inc.; Jubilant HollisterStier LLC; Biofortuna; Lyophilization Technology Inc.; and SYNERLAB GROUP.
The companies listed above are implementing various strategies that have resulted in the company’s growth and, in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.
Below is the list of the growth strategies done by the players operating in the lyophilization services for biopharmaceuticals market:
|
Year |
News |
| Nov-2022 | LTI was engaged in the development, process engineering, and preparation of clinical material of the tuberculosis vaccine candidate ID93 / GLA-SE. The tuberculosis vaccine has reached successful Phase 2 clinical testing. This study represents the first report on the successful lyophilization of a thermostable subunit vaccine candidate containing an emulsion-based adjuvant. |
| Feb-2022 | Lyophilization Technology, Inc. (LTI) successfully developed innovative technology for processing lyophilized products in dual-chamber cartridges and syringes. The unique and novel aspects of the innovation provide for processing a wide variety of products. These products span small molecules, biologics such as proteins, and vaccines. |
| Feb-2022 | Berkshire Sterile Manufacturing (BSM) has recently added formulation, lyophilization, and method development capabilities to complement their clients’ drug productions. BSM will now offer first-in-human formulation development, supply material for preclinical studies, and conduct research-level stability studies. BSM will also offer formulation optimization, process development, process optimization, and scale up studies. |
